Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years
Clinical trial NCT02787109 · COMPLETED
Trial details
- NCT number
- NCT02787109
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-07-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.